REBECA VIDAL CASADO-rekin lankidetzan egindako argitalpenak (8)

2022

  1. Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61-8048 after chronic intermittent ethanol in mice

    British Journal of Pharmacology, Vol. 179, Núm. 14, pp. 3711-3726

2021

  1. Addiction and the kynurenine pathway: A new dancing couple?

    Pharmacology and Therapeutics, Vol. 223

  2. Decreased kynurenine pathway potentiate resilience to social defeat effect on cocaine reward

    Neuropharmacology, Vol. 197

  3. Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor

    Neuropharmacology, Vol. 187

2020

  1. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102

2019

  1. Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens

    Neuropharmacology, Vol. 135, pp. 581-591

2017

  1. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus

    Neuropharmacology, Vol. 118, pp. 157-166